Midatech Pharma plc
MTP · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $2 | $3 | $2 | $2 |
| Gross Profit | -$2 | -$3 | -$2 | -$2 |
| % Margin | – | – | – | -2,612% |
| R&D Expenses | $2 | $3 | $2 | $2 |
| G&A Expenses | $2 | $2 | $2 | $1 |
| SG&A Expenses | $2 | $2 | $2 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$2 | -$3 | $0 | -$1 |
| Operating Expenses | $2 | $2 | $4 | $2 |
| Operating Income | -$4 | -$5 | -$4 | -$4 |
| % Margin | – | – | – | -4,542.2% |
| Other Income/Exp. Net | $0 | $2 | $1 | $0 |
| Pre-Tax Income | -$4 | -$3 | -$3 | -$4 |
| Tax Expense | $0 | -$0 | -$0 | -$0 |
| Net Income | -$4 | -$2 | -$3 | -$4 |
| % Margin | – | – | – | -4,230.1% |
| EPS | -15.06 | -3.65 | -7.92 | -1.13 |
| % Growth | -312.6% | 53.9% | -600.9% | – |
| EPS Diluted | -15.06 | -3.65 | -7.92 | -1.13 |
| Weighted Avg Shares Out | 0 | 6,195 | 248 | 3 |
| Weighted Avg Shares Out Dil | 0 | 6,195 | 248 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$4 | -$5 | -$3 | -$2 |
| % Margin | – | – | – | -2,755.4% |